+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

Antipsychotic Drugs: Technologies and Global Markets - Product Thumbnail Image

Antipsychotic Drugs: Technologies and Global Markets

  • Report
  • September 2018
  • 174 Pages
  • Global
From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Neurodegenerative Diseases Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurodegenerative Diseases Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 155 Pages
  • Global
From
From
From
From
Anti-Parkinson Drugs Market Report 2025 - Product Thumbnail Image

Anti-Parkinson Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Autism Spectrum Disorders Treatment Market Report 2025 - Product Thumbnail Image

Autism Spectrum Disorders Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • December 2024
  • 125 Pages
  • Global
From
Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Vascular Dementia - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Dementia - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
From
From
From
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
Loading Indicator